Dna Group (T.R.) Statistics
Total Valuation
TLV:DNA has a market cap or net worth of ILS 132.65 million. The enterprise value is 62.32 million.
Market Cap | 132.65M |
Enterprise Value | 62.32M |
Important Dates
The next estimated earnings date is Thursday, November 27, 2025.
Earnings Date | Nov 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TLV:DNA has 123.16 million shares outstanding. The number of shares has increased by 0.01% in one year.
Current Share Class | 123.16M |
Shares Outstanding | 123.16M |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | -0.02% |
Owned by Insiders (%) | 51.56% |
Owned by Institutions (%) | 0.12% |
Float | 59.66M |
Valuation Ratios
The trailing PE ratio is 268.85.
PE Ratio | 268.85 |
Forward PE | n/a |
PS Ratio | 433.49 |
PB Ratio | 1.35 |
P/TBV Ratio | 1.35 |
P/FCF Ratio | n/a |
P/OCF Ratio | 65.15 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 120.78 |
EV / Sales | 203.67 |
EV / EBITDA | n/a |
EV / EBIT | 221.00 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 48.83
Current Ratio | 48.83 |
Quick Ratio | 48.74 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.53% and return on invested capital (ROIC) is -0.83%.
Return on Equity (ROE) | 0.53% |
Return on Assets (ROA) | -0.81% |
Return on Invested Capital (ROIC) | -0.83% |
Return on Capital Employed (ROCE) | -1.32% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, TLV:DNA has paid 68,000 in taxes.
Income Tax | 68,000 |
Effective Tax Rate | 11.64% |
Stock Price Statistics
The stock price has increased by +21.56% in the last 52 weeks. The beta is -0.09, so TLV:DNA's price volatility has been lower than the market average.
Beta (5Y) | -0.09 |
52-Week Price Change | +21.56% |
50-Day Moving Average | 105.53 |
200-Day Moving Average | 102.70 |
Relative Strength Index (RSI) | 60.43 |
Average Volume (20 Days) | 113,708 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLV:DNA had revenue of ILS 306,000 and earned 516,000 in profits. Earnings per share was 0.00.
Revenue | 306,000 |
Gross Profit | 306,000 |
Operating Income | -1.30M |
Pretax Income | 584,000 |
Net Income | 516,000 |
EBITDA | n/a |
EBIT | -1.30M |
Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 70.33 million in cash and n/a in debt, giving a net cash position of 70.33 million or 0.57 per share.
Cash & Cash Equivalents | 70.33M |
Total Debt | n/a |
Net Cash | 70.33M |
Net Cash Per Share | 0.57 |
Equity (Book Value) | 98.23M |
Book Value Per Share | 0.80 |
Working Capital | 69.02M |
Cash Flow
Operating Cash Flow | 2.04M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -424.18% and 168.63%.
Gross Margin | 100.00% |
Operating Margin | -424.18% |
Pretax Margin | 190.85% |
Profit Margin | 168.63% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TLV:DNA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | n/a |
Earnings Yield | 0.39% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on November 10, 2019. It was a reverse split with a ratio of 0.1666666667.
Last Split Date | Nov 10, 2019 |
Split Type | Reverse |
Split Ratio | 0.1666666667 |
Scores
TLV:DNA has an Altman Z-Score of 37.57 and a Piotroski F-Score of 4.
Altman Z-Score | 37.57 |
Piotroski F-Score | 4 |